EVH Evolent Health, Inc Class A Common Stock

NYSE · US · Healthcare · Health Information Services · evolent.com

3.460USD0.00%Mkt Cap: 391.19M $P/E: —Today

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc. Class A Common Stock

$44.25BUSDP/E 44.9

TEM

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

$11.92BUSDP/E 53.8

HNGE

Hinge Health, Inc. Class A Common Stock

$7.88BUSDP/E 11.9

HQY

HealthEquity, Inc. - Common Stock

$7.45BUSDP/E 32.5

DOCS

Doximity, Inc. Class A Common Stock

$4.98BUSDP/E 31.0

WAY

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

CERT

Certara, Inc. - Common Stock

$1.43BUSD

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

$1.12BUSDP/E 54.7

TDOC

Teladoc Health, Inc. Common Stock

$1.00BUSD

HSTM

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

$686.98MUSD

PHR

Phreesia, Inc. Common Stock

$625.05MUSDP/E 55.9

WEAV

Weave Communications, Inc. Common Stock

$592.92MUSD

RAY-B

RaySearch Laboratories AB Class B

$516.00MUSDP/E 29.1

Key Statistics

Company

Market Cap391.19M USD

Enterprise Value1.25B USD

Revenue (TTM)2.10B USD

Gross Profit399.88M USD

Net Income (TTM)-534.51M USD

Revenue/Share18.64 USD

Last Price3.460 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4.2K

CountryUS

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)8.57

PEG1.93

EV/EBITDA20.41

EV/Revenue0.59

P/S0.19

P/B1.02

EPS (TTM)-4.49

EPS (Forward)0.40

52W Range

2.09520% of range8.805

52W High8.805 USD

52W Low2.095 USD

Profitability

Gross Margin21.31%

Oper. Margin-1.34%

EBITDA Margin2.91%

Profit Margin-28.49%

ROE-128.74%

ROA-28.14%

Growth

Revenue Growth46.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF38.84M USD

CapEx (TTM)34.09M USD

FCF Margin8.79%

FCF Yield47.11%

Net Debt854.73M USD

Net Debt/EBITDA14.00

Balance Sheet

Debt/Equity2.38

Current Ratio1.24

Quick Ratio1.15

Book Value/Sh3.40 USD

Cash/Share1.02 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)5.750 USD

Upside (mean)+66.2%

Target Range3.000 USD – 8.000 USD

3.000+66.2% to mean8.000

# Analysts12

Ownership

Shares Out.113.06M

Float94.21M

Insiders3.10%

Institutions101.31%

Short Interest

Short Ratio5.5d

Short % Float12.58%

Short % Out.12.44%

Shares Short14.07M

Short (prev mo.)15.77M

Technical

SMA 503.990 (-13.3%)

SMA 2003.833 (-9.7%)

Beta0.84

S&P 52W Chg14.58%

Avg Vol (30d)1.96M

Avg Vol (10d)2.15M

Technical Indicators

RSI (14)34.8

MACD-0.2227

MACD Signal-0.2033

MACD Hist.-0.0194

BB Upper4.371 USD

BB Middle3.787 USD

BB Lower3.203 USD

BB Width30.85%

ATR (14)0.2223 USD

Vol Ratio (20d)0.94x